Back to search
FDAFDA · Food and drugs·Recall number D-0153-2018

Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10

Published January 17, 2018 · Recall initiated: December 5, 2017

Summary

FDA records drug Class III recall D-0153-2018, published January 17, 2018 and initiated December 5, 2017. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Terminated; Reported quantity: 11,474 cartons of 10 syringes per carton; Lot: Lot #: 7S572, Exp. 04/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

What to do

Voluntary: Firm initiated · Letter

Get an email if ENOXAPARIN SODIUM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ENOXAPARIN SODIUM
Manufacturer
Sanofi-Aventis U.S. LLC
Distributor
Distributed nationwide.
Lot
Lot #: 7S572, Exp. 04/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10 recalled?

Yes. FDA published recall D-0153-2018 on January 17, 2018. Reported hazard: Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ENOXAPARIN SODIUM.